Published in Curr Eye Res on August 01, 1997
Trichostatin a inhibits corneal haze in vitro and in vivo. Invest Ophthalmol Vis Sci (2009) 1.31
Electric field-directed cell motility involves up-regulated expression and asymmetric redistribution of the epidermal growth factor receptors and is enhanced by fibronectin and laminin. Mol Biol Cell (1999) 1.29
Corneal stroma PDGF blockade and myofibroblast development. Exp Eye Res (2008) 1.08
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf (2012) 1.08
Post-LASIK tear dysfunction and dysesthesia. Ocul Surf (2010) 0.95
iTRAQ quantitative proteomics in the analysis of tears in dry eye patients. Invest Ophthalmol Vis Sci (2012) 0.94
The corneal fibrosis response to epithelial-stromal injury. Exp Eye Res (2016) 0.92
Thrombomodulin promotes corneal epithelial wound healing. PLoS One (2015) 0.80
Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis. J Ophthalmol (2015) 0.75
Connective tissue growth factor is not necessary for haze formation in excimer laser wounded mouse corneas. PLoS One (2017) 0.75
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell (1999) 5.01
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med (1988) 4.67
Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study. Am J Transplant (2005) 2.01
Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci (2000) 1.96
Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant (2001) 1.87
Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Med (1987) 1.80
Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (1997) 1.74
Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease. Clin Nephrol (2002) 1.64
Enalapril treatment of a nursing with slightly impaired renal function. Clin Nephrol (1989) 1.52
Long-term survival in idiopathic membranous glomerulonephritis: can the course be clinically predicted? Clin Nephrol (1994) 1.51
Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J Intern Med (1989) 1.44
Corneal stromal changes induced by myopic LASIK. Invest Ophthalmol Vis Sci (2000) 1.43
Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog (1996) 1.41
Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis. Clin Nephrol (1995) 1.39
Elevated angiotensin I-converting enzyme in histiocytic medullary reticulosis. N Engl J Med (1983) 1.29
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia (1998) 1.25
Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. Nephrol Dial Transplant (2000) 1.25
Reduced amyloid-A-degrading activity in serum in amyloidosis associated with rheumatoid arthritis. Br Med J (Clin Res Ed) (1982) 1.20
Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis. Scand J Respir Dis (1978) 1.16
Epidermal growth factor is a constant component of normal human tear fluid. Graefes Arch Clin Exp Ophthalmol (1989) 1.14
Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J Clin Virol (2004) 1.14
Immunoturbidimetry of albumin and immunoglobulin G in urine. Clin Chem (1982) 1.13
Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum (1989) 1.12
Starting a home hemodialysis program: single center experiences. Scand J Urol Nephrol (2002) 1.11
Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. Am Rev Respir Dis (1978) 1.11
Letter: Negative complement-fixation tests as an immunopathological finding. Lancet (1974) 1.10
Tumor necrosis factor in children with malignancies. Cancer Res (1990) 1.09
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis. Kidney Int (2000) 1.09
The effects of experimental tear film removal on corneal surface regularity and barrier function. Ophthalmology (2000) 1.08
Release of TGF-beta 1 and VEGF in tears following photorefractive keratectomy. Curr Eye Res (1997) 1.07
Acute phase response in dairy cows with experimentally induced Escherichia coli mastitis. Acta Vet Scand (1999) 1.07
Immunohistochemical demonstration of substance P in the lower respiratory tract of the rabbit and not of man. Thorax (1983) 1.04
Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes (1986) 1.04
Human tear fluid PDGF-BB, TNF-alpha and TGF-beta1 vs corneal haze and regeneration of corneal epithelium and subbasal nerve plexus after PRK. Exp Eye Res (2001) 1.03
Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease. Liver (1984) 1.03
Atrophic gastritis in Sjögren's syndrome. Morphologic, biochemical, and immunologic findings. Arthritis Rheum (1985) 1.03
Increased release of tumour necrosis factor-alpha in human tear fluid after excimer laser induced corneal wound. Br J Ophthalmol (1997) 1.01
Plasma catecholamines in severely injured patients: a prospective study on 45 patients with multiple injuries. Br J Surg (1975) 1.01
Mechanism of reduced amyloid-A-degrading activity in serum of patients with secondary amyloidosis. Lancet (1982) 1.00
Comparison of plasma polymerase chain reaction and pp65-antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients. J Clin Virol (2001) 1.00
Effects of oleoresin capsicum pepper spray on human corneal morphology and sensitivity. Invest Ophthalmol Vis Sci (2000) 0.99
Real-time confocal microscopic observations on human corneal nerves and wound healing after excimer laser photorefractive keratectomy. Curr Eye Res (1997) 0.99
Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol Dial Transplant (1997) 0.99
Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J (Clin Res Ed) (1983) 0.99
Effect of sensory and sympathetic denervation on substance P immunoreactivity in nerve fibres of the rabbit eye. Exp Eye Res (1982) 0.97
Glomerular IgA deposits in patients with celiac disease. Clin Nephrol (1990) 0.97
Vascular changes in erythropoietic protoporphyria: histopathologic and immunohistochemical study. J Am Acad Dermatol (2000) 0.96
Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection. Clin Nephrol (1984) 0.96
Plasmin in tear fluid of patients with corneal ulcers: basis for new therapy. Acta Ophthalmol (Copenh) (1987) 0.95
Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis (1982) 0.95
Expression of tenascin and cellular fibronectin in the rabbit cornea after anterior keratectomy. Immunohistochemical study of wound healing dynamics. Invest Ophthalmol Vis Sci (1991) 0.94
Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes. Diabetologia (1999) 0.94
Angiotensin converting enzyme in cerebrospinal fluid: a new assay. Neurology (1985) 0.94
Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes (1998) 0.94
Early rise in serum concentration of transferrin receptor induced by recombinant human erythropoietin in very-low-birth-weight infants. Pediatr Res (1994) 0.94
Familial occurrence of sarcoidosis and Crohn's disease. Lancet (1983) 0.93
Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis. Kidney Int (1995) 0.93
Serological response to Chlamydia pneumoniae in patients with sarcoidosis. J Infect (1996) 0.92
Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus. Rheumatol Int (1992) 0.92
Expression of cellular fibronectin and tenascin in the rabbit cornea after excimer laser photorefractive keratectomy: a 12 month study. Br J Ophthalmol (1995) 0.91
Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1993) 0.91
Immunoreactivity for substance P in the Gasserian ganglion, ophthalmic nerve and anterior segment of the rabbit eye. Histochem J (1981) 0.91
Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation (1992) 0.91
Tuberculosis and renal allograft transplantation. Transplant Proc (1987) 0.91
Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion. Laryngoscope (2000) 0.91
Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia (1995) 0.91
In vivo confocal microscopy: a new possibility to confirm the diagnosis of Borrelia keratitis? Cornea (1996) 0.90
Mesangial glomerulonephritis as an extra-articular manifestation of rheumatoid arthritis. Br J Rheumatol (1997) 0.90
High pleural fluid hyaluronan concentrations in rheumatoid arthritis. Eur Respir J (1999) 0.90
Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations. Acta Ophthalmol Suppl (1992) 0.90
Angiotensin-converting enzyme. I. Activity and correlation with serum lysozyme in sarcoidosis, other chest or lymph node diseases and healthy persons. Scand J Respir Dis (1979) 0.90
Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland. J Intern Med (2010) 0.90
Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care (2000) 0.90
Erythropoietin and renin substrate in cerebellar haemangioblastoma. Acta Med Scand (1985) 0.90
Corneal wound healing and nerve morphology after excimer laser in situ keratomileusis in human eyes. J Refract Surg (1997) 0.90
Postoperative inflammation, microbial complications, and wound healing following laser in situ keratomileusis. J Refract Surg (2001) 0.90
Adhesion molecules and urinary tumor necrosis factor-alpha in idiopathic membranous glomerulonephritis. Kidney Int (1998) 0.89
Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator. Ann Med (1991) 0.89
Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus. Nephrol Dial Transplant (1998) 0.89
Histochemical evidence of limited reinnervation of human corneal grafts. Acta Ophthalmol (Copenh) (1985) 0.89
Substance P-immunoreactive nerves in the human cornea and iris. Invest Ophthalmol Vis Sci (1982) 0.89
Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant (1994) 0.89
Renal growth and function 11-28 years after treatment of Wilms' tumour. Eur J Pediatr (1991) 0.88
Surface-associated activation of plasminogen on gram-positive bacteria. Effect of plasmin on the adherence of Staphylococcus aureus. Acta Ophthalmol Suppl (1992) 0.88
Effects of psychological stress on plasma interleukins-1 beta and 6, C-reactive protein, tumour necrosis factor alpha, anti-diuretic hormone and serum cortisol. Scand J Clin Lab Invest (1993) 0.87
Immunoelectrophoretic 'tailing' of albumin line due to albumin-IgG antibody complexes: a side effect of nitrofurantoin treatment? Scand J Immunol (1976) 0.87